Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
IONIS PHARMACEUTICALS INC (IONS)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 8-K | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 1.4% | 1.9% | 2.4% | 1.4% | 1.7% | 1.5% | 1.3% | 1.8% |
Gross profit | 98.6% | 98.1% | 97.6% | 98.6% | 98.3% | 98.5% | 98.7% | 98.2% |
Selling, general and administrative | 27.7% | 28.1% | | 16.0% | 16.1% | 18.9% | | 43.5% |
General and administrative | | | 8.2% | | | | 4.6% | |
EBITDA | -72.7% | -79.0% | -67.0% | 4.1% | 1.1% | 2.6% | -1.5% | -38.7% |
Depreciation | 1.9% | | 2.4% | 1.7% | 1.8% | 1.8% | 1.9% | 2.3% |
EBITA | -74.6% | -80.9% | -69.4% | 2.4% | -0.7% | 0.8% | -3.4% | -41.0% |
Amortization of intangibles | 0.1% | | 0.4% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
EBIT | -74.7% | -81.0% | -69.8% | 2.1% | -1.0% | 0.5% | -3.7% | -41.4% |
Pre-tax income | -44.6% | -53.2% | -43.9% | 1.3% | -3.0% | -0.4% | -3.6% | -40.7% |
Income taxes | 4.3% | 3.8% | 2.0% | 0.5% | 0.3% | 0.0% | -0.1% | 51.5% |
Net income | -48.9% | -57.0% | -45.9% | 0.8% | -3.3% | -0.5% | -3.5% | -92.0% |
|